A Phase 3, Randomized, Double-Blind, Multinational, Placebo-Controlled Study toEvaluate Efficacy and Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding,anti-CD3 Monoclonal Antibody, in Children and Adolescents with Newly Diagnosed Type1 Dia

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences